|
|
Blood, 15 March 2007, Vol. 109, No. 6, pp. 2649-2656.
Prepublished online as a Blood First Edition Paper on November 9, 2006; DOI 10.1182/blood-2006-08-044529.
 Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
Vu H. Nguyen1,
Robert Zeiser1,
Daniel L. daSilva1,
Daisy S. Chang1,
Andreas Beilhack1,
Christopher H. Contag2, and
Robert S. Negrin1
1 Department of Medicine, Division of Bone Marrow Transplantation, Stanford University, Stanford, CA;
2 Departments of Pediatrics, Radiology, and Microbiology & Immunology, Stanford University, Stanford, CA
CD4+CD25+ regulatory T cells (Tregs) suppress immune responses to alloantigens. The in vivo circulation and tissue localization of Tregs during an adaptive immune response remain unclear. We noninvasively tracked luciferase-expressing Tregs over time in an allogeneic bone marrow transplant model and demonstrated colocalization with effector T cells and initial expansion in secondary lymphoid organs before migration into inflamed tissues. Inflammation induced by irradiation and the allogeneic setting provided crucial stimuli for early Treg expansion and migration, leading to parallel reduction of effector T-cell proliferation in lymphoid organs and peripheral tissues. Treg transplants conferred long-term protection from systemic inflammatory challenge consistent with Treg in vivo survival. Suppression occurred during multiple phases of inflammation, but is optimal in the initial phase, providing protection from graft-versus-host disease while maintaining the graft-versus-tumor effect even at physiologic doses of Tregs due to their in vivo expansion, hence overcoming a major barrier to potential clinical applications of Tregs given their rarity.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. J. Akins and P. Dubey
Noninvasive Imaging of Cell-Mediated Therapy for Treatment of Cancer
J. Nucl. Med.,
June 1, 2008;
49(Suppl_2):
180S - 195S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. H. Nguyen, S. Shashidhar, D. S. Chang, L. Ho, N. Kambham, M. Bachmann, J. M. Brown, and R. S. Negrin
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation
Blood,
January 15, 2008;
111(2):
945 - 953.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Bestard, J. M. Cruzado, M. Mestre, A. Caldes, J. Bas, M. Carrera, J. Torras, I. Rama, F. Moreso, D. Seron, et al.
Achieving Donor-Specific Hyporesponsiveness Is Associated with FOXP3+ Regulatory T Cell Recruitment in Human Renal Allograft Infiltrates
J. Immunol.,
October 1, 2007;
179(7):
4901 - 4909.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Zeiser, V. H. Nguyen, J.-Z. Hou, A. Beilhack, E. Zambricki, M. Buess, C. H. Contag, and R. S. Negrin
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
Blood,
March 1, 2007;
109(5):
2225 - 2233.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
